Haemonetics Corp (HAE) · Oct 8, 2026 · Material agreement

Haemonetics supply deal expands to all CSL U.S. centers

CSL rollout expanded — All current U.S. centers; rollout by end-2027

Haemonetics’ CSL supply agreement now points to a full U.S. center rollout by 2027, but the financial payoff remains unquantified until November.

Haemonetics is leaning on Plasma as a core growth engine after losing CSL-related revenue during the prior customer transition; Plasma represented 39.3% of fiscal 2026 revenue, while organic Plasma growth excluding the prior CSL impact was 19.6%. The commercial opportunity is materially larger than first disclosed. The August agreement only contemplated a portion of CSL’s U.S. centers with scope and timing still undetermined; CSL now anticipates transitioning equipment and disposables across all of its current U.S. plasma collection centers by the end of calendar 2027. 〔0〕

This is an upgrade in potential, not yet a financial upgrade. The agreement remains non-exclusive and contains no minimum purchase commitments, so the full-center plan does not yet establish the actual purchase volume or revenue contribution. Haemonetics therefore left fiscal 2027 guidance unchanged. 〔1〕

The next disclosure should convert the rollout headline into numbers. Management expects to discuss the agreement’s anticipated fiscal 2027 impact on its second-quarter earnings call in November 2026. 〔2〕

Bottom line: This strengthens Haemonetics’ Plasma growth story by expanding the likely customer footprint from a partial rollout to CSL’s entire current U.S. network. It matters, but the earnings impact remains unproven until purchase volumes and timing are disclosed in November.

What to watch next

Q2 fiscal 2027 earnings call, November 2026

Original filing on SEC EDGAR

More Haemonetics Corp news

Haemonetics supply deal expands to all CSL U.S. centers | HAE Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.